How to reverse post-viral anosmia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Post-Viral Anosmia

Olfactory training should be initiated immediately and continued for a minimum of 3-6 months as the primary evidence-based treatment for post-viral anosmia. 1

Primary Treatment Approach

Olfactory Training (First-Line Therapy)

  • Start olfactory training immediately upon diagnosis and continue for at least 3-6 months, as recommended by the European Rhinologic Society 1
  • Patients should be referred to validated resources for proper training technique (such as www.fifthsense.org.uk) 2
  • This intervention has moderate strength of evidence and represents the cornerstone of management 1

Initial Assessment Requirements

  • Perform objective psychophysical testing using validated instruments (UPSIT or Sniffin'Sticks) rather than relying on patient self-assessment, as patients typically cannot accurately gauge their impairment severity 1
  • Conduct rigid nasal endoscopy to differentiate between conductive and sensorineural causes 1
  • Document temporal relationship to viral infection, associated symptoms (nasal obstruction, rhinorrhea, flu-like illness), and predisposing factors 1

Recovery Timeline and Prognosis

Expected Natural History

  • Recovery occurs in 44-73% of COVID-19 patients within the first month, though some develop persistent dysfunction 2, 1
  • Complete resolution was seen in 13% and partial resolution in 14% of patients, with mean time to improvement of 7.2 days in early reports 2
  • Recovery typically takes place within a few weeks, but longer timeframes are possible 2
  • One case series showed recovery by day 17 in one patient, while others had persistent dysfunction requiring ongoing management 2

Adjunctive Treatment Considerations

Corticosteroid Therapy (Limited Evidence)

  • The evidence for systemic corticosteroids combined with intranasal steroid/mucolytic/decongestant solution is very uncertain based on one small study of 18 participants 3
  • This study showed 5/9 participants in the treatment group achieved normal olfactory function (CCCRC score ≥90) compared to 0/9 in the control group after 40 days, but the confidence interval was extremely wide (RR 11.00,95% CI 0.70 to 173.66) 3
  • Given the very low-certainty evidence, corticosteroids should not be routinely recommended as first-line therapy 3

Treating Underlying Sinonasal Disease

  • Address any sinonasal inflammatory disease with appropriate medical or surgical management before or concurrent with olfactory training 1
  • This is particularly important if nasal endoscopy reveals obstructive pathology 1

Follow-Up Protocol

Structured Monitoring Schedule

  • Re-evaluate patients at 1 month, 3 months, and 6 months after initiating treatment 1, 4
  • Repeat objective psychophysical testing at each follow-up visit to document changes objectively 1
  • Refer to an otolaryngologist or specialized smell/taste clinic if no improvement occurs after 3-6 months of olfactory training 1, 4

Supportive Management

Dietary and Quality of Life Interventions

  • Refer patients to a registered dietitian for counseling on flavor enhancement, additional seasoning, and expanding dietary options 1, 4
  • Address safety concerns related to inability to detect spoiled food or gas leaks 4
  • Provide counseling about the impact on quality of life, as persistent olfactory dysfunction can have profound effects 3

Common Pitfalls to Avoid

Diagnostic Errors

  • Do not rely on patient self-assessment of olfactory function severity, as objective testing reveals much higher rates of dysfunction (98.3% by UPSIT testing even when only 35% reported complaints) 5
  • Do not order unnecessary neuroimaging (CT/MRI) when there is a clear temporal relationship to viral infection and no red flag symptoms (facial pain, serosanguinous discharge, visual changes) 2, 4

Treatment Misconceptions

  • Do not prescribe systemic corticosteroids routinely, as the evidence is very uncertain and limited to one very small study 3
  • Do not delay initiation of olfactory training while waiting for spontaneous recovery, as early intervention is recommended 1
  • Recognize that most "taste loss" actually reflects loss of retronasal olfaction (flavor perception) rather than true taste dysfunction 5

COVID-19 Specific Considerations

  • Perform COVID-19 testing in all patients with sudden-onset olfactory dysfunction, especially during pandemic periods, as anosmia may be the sole presenting symptom 1, 4
  • Advise self-isolation as recommended by the World Health Organization for patients with anosmia during active infection periods 5

Alternative Approaches (Emerging Evidence)

Integrative Medicine

  • One case study reported complete recovery within 4 months using Ayurveda (Shadbindu taila nasya) combined with Traditional Chinese Acupuncture at specific points (GV.20, LI.20, Ex.1, H.7, LI.11, GB.8, GB.21, GV.25) 6
  • However, this represents very low-quality evidence from a single case report and cannot be recommended as standard practice 6

References

Guideline

Evaluation and Management of Chronic Loss of Taste and Smell

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.

The Cochrane database of systematic reviews, 2021

Guideline

Workup for Loss of Taste Sensation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clinical Presentation and Recovery of Taste Loss After Viral Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.